In the nicest way it is great that we are actually competing but only competing in terms of timing of phase 2 results. Theirs hits very soon but nevertheless we both are running great lengths. What we don't want is to Factor in disaster and turn up that our products are no better than exisiting. We have to show we are unique, safe and more effective. No mean feat but lets look at OUR paradigm being turned into a quarter. Just for starters.
Ann: Botanix receives A$4.6m R&D Tax Incentive refund, page-37
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 35.0¢ | $335.6K | 951.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 199121 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 188812 | 12 |
View Market Depth
| Last trade - 11.58am 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
